What You Should Know:
-OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, today announced it has become the first electronic health record (EHR) company to offer its real world data (RWD) dataset on Datavant Connect powered by AWS Clean Rooms through its Lighthouse Partner Program.
- This collaboration builds upon the success of OMNY Health and Datavant’s longstanding relationship to enhance clinical research and drug development.
OMNY Health
Read More
real-world data (RWD)
Century Health to Curate Real World EHR Data for MS Research and Treatments
What You Should Know:
- Century Health, a provider in applying artificial intelligence (AI) to real-world data for research acceleration, and Nira Medical, a national leader in neurological care delivery, announced a strategic partnership to advance the understanding of multiple sclerosis (MS) and improve patient outcomes.
- The collaboration will leverage Century Health's AI platform to curate and structure data from over 3,000 MS patients treated within Nira Medical's network of
Read More
Guardant Health and ConcertAI Partner to Unlock Cancer Insights with Multi-Modal Real-World Data
What You Should Know:
- Guardant Health, a provider in precision oncology, and ConcertAI, a real-world evidence (RWE) and AI technology company in oncology, announced a strategic collaboration that will provide biopharmaceutical companies with access to a first-of-its-kind multi-modal real-world data (RWD) solution.
- The partnership integrates comprehensive patient electronic medical record (EMR) data with genomic and epigenomic tumor profiling information, offering a deeper
Read More
Optimizing Clinical Trials with AI and Data-Driven Insights
While most technology- and innovation-oriented industries have followed the general principles of Moore’s Law, which holds that computing power would double yearly, while costs were cut in half, the life sciences industry appears to be spending more money developing fewer drugs.
According to the latest data, the cost to take a drug candidate from the discovery stage, all the way to market launch, hit $2.3 billion in 2022—a $298 million rise from 2021. Meanwhile, there were
Read More
Unlocking Real-World Data to Advance Precision Medicine in 2025
The healthcare industry is a wellspring of data, from electronic health records to data from wearables, health insurance claims, and a multitude of real-world data (RWD) points. While RWD has been utilized to improve drug discovery and clinical services, recent technological advances in data management, artificial intelligence, and bioinformatics are beginning to reveal its transformative potential in healthcare, especially within precision medicine. As the industry seeks to employ new
Read More
Ontada, Datavant Partner to Accelerate Oncology Innovation with Real-World Data
What You Should Know:
- Ontada, a McKesson business specializing in real-world data and clinical technology for community oncology, has announced a strategic collaboration with Datavant, a health data platform.
- The partnership aims to accelerate oncology innovation by providing life science companies with faster access to Ontada's comprehensive real-world data.
In October, Ontada partnered with Microsoft to utilize AI capabilities to extract actionable insights from vast
Read More
Flatiron Health and Lifebit Partner to Enhance Cancer Care in Japan through Real-World Data
What You Should Know:
- Flatiron Health, and Lifebit Biotech Ltd (UK, London; hereafter “Lifebit”), are expanding their collaboration into Japan to transform cancer care, facilitating ground breaking research by allowing for safe and secure access to real-world data (RWD).
- Building on the success of their multi-year strategic partnership, Lifebit’s pioneering federated Trusted Research Environment (TRE) technology will enable safe and secure access to Flatiron Health’s high-quality
Read More
Panalgo Partners with COTA to Enhance AI & RWD-Enabled Cancer Care
What You Should Know:
- Panalgo, a provider of healthcare data analytics solutions, has announced a partnership with COTA, an organization focused on providing real-world data (RWD) for cancer care.
- The strategic collaboration will enable COTA to make its high-quality hematologic oncology data available through Panalgo's Instant Health Data Analytics (IHD) platform.
Leveraging COTA's Real-World Data
COTA's RWD is derived from electronic health records (EHRs) and offers
Read More
COTA and FDA Extend Collaboration to Advance Use of Real-World Data in Cancer Research
What You Should Know:
- COTA, a leader in real-world data and analytics solutions, today announced a five-year extension of its research collaboration with the U.S. Food and Drug Administration's (FDA) Oncology Center of Excellence (OCE).
- The five-year extension builds upon a successful partnership established in 2018 and signifies a continued commitment to utilizing real-world data (RWD) to enhance cancer treatment and regulatory decisions.
Building on a Successful
Read More
COTA & Sanofi Partner to Leverage Real-World Data and AI to Accelerate Cancer Trials
What You Should Know:
- COTA, a leading real-world data (RWD) and analytics company in oncology, has announced a new collaboration with Sanofi.
- The strategic partnership aims to leverage RWD and artificial intelligence (AI) to accelerate clinical trials specifically focused on multiple myeloma, a cancer affecting white blood cells. The findings from this partnership have the potential to significantly impact future clinical trial designs for multiple myeloma.
Unlocking
Read More
